Reduced Oxidative Stress and Enhanced FGF21 Formation in Livers of Endurance-Exercised Rats with Diet-Induced NASH

Nutrients. 2019 Nov 8;11(11):2709. doi: 10.3390/nu11112709.

Abstract

Non-alcoholic fatty liver diseases (NAFLD) including the severe form with steatohepatitis (NASH) are highly prevalent ailments to which no approved pharmacological treatment exists. Dietary intervention aiming at 10% weight reduction is efficient but fails due to low compliance. Increase in physical activity is an alternative that improved NAFLD even in the absence of weight reduction. The underlying mechanisms are unclear and cannot be studied in humans. Here, a rat NAFLD model was developed that reproduces many facets of the diet-induced NAFLD in humans. The impact of endurance exercise was studied in this model. Male Wistar rats received control chow or a NASH-inducing diet rich in fat, cholesterol, and fructose. Both diet groups were subdivided into a sedentary and an endurance exercise group. Animals receiving the NASH-inducing diet gained more body weight, got glucose intolerant and developed a liver pathology with steatosis, hepatocyte hypertrophy, inflammation and fibrosis typical of NAFLD or NASH. Contrary to expectations, endurance exercise did not improve the NASH activity score and even enhanced hepatic inflammation. However, endurance exercise attenuated the hepatic cholesterol overload and the ensuing severe oxidative stress. In addition, exercise improved glucose tolerance possibly in part by induction of hepatic FGF21 production.

Keywords: FGF21; NAFLD; NASH; cholesterol; endurance exercise; glucose intolerance; oxidative stress.

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Diet, High-Fat
  • Dietary Sugars
  • Disease Models, Animal
  • Down-Regulation
  • Exercise Therapy* / adverse effects
  • Fibroblast Growth Factors / metabolism*
  • Fructose
  • Liver / metabolism*
  • Liver / pathology
  • Male
  • Non-alcoholic Fatty Liver Disease / etiology
  • Non-alcoholic Fatty Liver Disease / metabolism
  • Non-alcoholic Fatty Liver Disease / pathology
  • Non-alcoholic Fatty Liver Disease / therapy*
  • Oxidative Stress*
  • Physical Conditioning, Animal* / adverse effects
  • Physical Endurance*
  • Rats, Wistar
  • Signal Transduction

Substances

  • Blood Glucose
  • Dietary Sugars
  • FGF22 protein, rat
  • Fructose
  • Fibroblast Growth Factors